Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Kanabo Group (KNB) Competitors

Kanabo Group logo
GBX 0.22 0.00 (0.00%)
As of 05/15/2026

KNB vs. TLY, SPI, MGP, SBI, and OPTI

Should you buy Kanabo Group stock or one of its competitors? MarketBeat compares Kanabo Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Kanabo Group include Totally (TLY), Spire Healthcare Group (SPI), Medica Group (MGP), Sourcebio International (SBI), and OptiBiotix Health (OPTI). These companies are all part of the "medical" sector.

How does Kanabo Group compare to Totally?

Totally (LON:TLY) and Kanabo Group (LON:KNB) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, valuation, profitability, analyst recommendations, risk, dividends and earnings.

51.3% of Totally shares are held by institutional investors. Comparatively, 3.8% of Kanabo Group shares are held by institutional investors. 13.3% of Totally shares are held by company insiders. Comparatively, 24.3% of Kanabo Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Kanabo Group had 1 more articles in the media than Totally. MarketBeat recorded 2 mentions for Kanabo Group and 1 mentions for Totally. Totally's average media sentiment score of 0.75 beat Kanabo Group's score of 0.00 indicating that Totally is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Totally
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Kanabo Group
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Totally has a beta of 0.55, suggesting that its stock price is 45% less volatile than the broader market. Comparatively, Kanabo Group has a beta of 3.04, suggesting that its stock price is 204% more volatile than the broader market.

Totally has higher revenue and earnings than Kanabo Group. Kanabo Group is trading at a lower price-to-earnings ratio than Totally, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Totally£133.05M0.00-£3.79M-£1.93N/A
Kanabo Group£1.14M1.25-£8.18M-£1.42N/A

Totally has a net margin of -2.94% compared to Kanabo Group's net margin of -892.40%. Totally's return on equity of -8.85% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Totally-2.94% -8.85% -2.42%
Kanabo Group -892.40%-80.03%-20.89%

Summary

Totally beats Kanabo Group on 8 of the 13 factors compared between the two stocks.

How does Kanabo Group compare to Spire Healthcare Group?

Kanabo Group (LON:KNB) and Spire Healthcare Group (LON:SPI) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, media sentiment, profitability, dividends, analyst recommendations and valuation.

Kanabo Group has a beta of 3.04, meaning that its stock price is 204% more volatile than the broader market. Comparatively, Spire Healthcare Group has a beta of 0.907, meaning that its stock price is 9% less volatile than the broader market.

Spire Healthcare Group has a net margin of 1.04% compared to Kanabo Group's net margin of -892.40%. Spire Healthcare Group's return on equity of 2.22% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Kanabo Group-892.40% -80.03% -20.89%
Spire Healthcare Group 1.04%2.22%3.73%

Spire Healthcare Group has a consensus target price of GBX 276, suggesting a potential upside of 23.77%. Given Spire Healthcare Group's stronger consensus rating and higher probable upside, analysts clearly believe Spire Healthcare Group is more favorable than Kanabo Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kanabo Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Spire Healthcare Group
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Spire Healthcare Group had 8 more articles in the media than Kanabo Group. MarketBeat recorded 10 mentions for Spire Healthcare Group and 2 mentions for Kanabo Group. Spire Healthcare Group's average media sentiment score of 0.34 beat Kanabo Group's score of 0.00 indicating that Spire Healthcare Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Kanabo Group
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Spire Healthcare Group
0 Very Positive mention(s)
4 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Spire Healthcare Group has higher revenue and earnings than Kanabo Group. Kanabo Group is trading at a lower price-to-earnings ratio than Spire Healthcare Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kanabo Group£1.14M1.25-£8.18M-£1.42N/A
Spire Healthcare Group£1.58B0.57£28.15M£4.0055.75

3.8% of Kanabo Group shares are owned by institutional investors. Comparatively, 23.4% of Spire Healthcare Group shares are owned by institutional investors. 24.3% of Kanabo Group shares are owned by insiders. Comparatively, 39.2% of Spire Healthcare Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Spire Healthcare Group beats Kanabo Group on 14 of the 16 factors compared between the two stocks.

How does Kanabo Group compare to Medica Group?

Kanabo Group (LON:KNB) and Medica Group (LON:MGP) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, media sentiment, dividends, profitability, valuation and risk.

Medica Group has a net margin of 9.35% compared to Kanabo Group's net margin of -892.40%. Medica Group's return on equity of 12.42% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Kanabo Group-892.40% -80.03% -20.89%
Medica Group 9.35%12.42%6.62%

In the previous week, Kanabo Group had 2 more articles in the media than Medica Group. MarketBeat recorded 2 mentions for Kanabo Group and 0 mentions for Medica Group. Kanabo Group's average media sentiment score of 0.00 equaled Medica Group'saverage media sentiment score.

Company Overall Sentiment
Kanabo Group Neutral
Medica Group Neutral

3.8% of Kanabo Group shares are held by institutional investors. Comparatively, 88.4% of Medica Group shares are held by institutional investors. 24.3% of Kanabo Group shares are held by insiders. Comparatively, 2.9% of Medica Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Medica Group has higher revenue and earnings than Kanabo Group. Kanabo Group is trading at a lower price-to-earnings ratio than Medica Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kanabo Group£1.14M1.25-£8.18M-£1.42N/A
Medica Group£76.98M0.00£7.20M£0.06N/A

Kanabo Group has a beta of 3.04, suggesting that its share price is 204% more volatile than the broader market. Comparatively, Medica Group has a beta of 1.1, suggesting that its share price is 10% more volatile than the broader market.

Summary

Medica Group beats Kanabo Group on 8 of the 11 factors compared between the two stocks.

How does Kanabo Group compare to Sourcebio International?

Kanabo Group (LON:KNB) and Sourcebio International (LON:SBI) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, media sentiment, risk and profitability.

3.8% of Kanabo Group shares are held by institutional investors. 24.3% of Kanabo Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Sourcebio International has higher revenue and earnings than Kanabo Group. Kanabo Group is trading at a lower price-to-earnings ratio than Sourcebio International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kanabo Group£1.14M1.25-£8.18M-£1.42N/A
Sourcebio International£75.61M0.00N/A£0.09N/A

Sourcebio International has a net margin of 0.00% compared to Kanabo Group's net margin of -892.40%. Sourcebio International's return on equity of 0.00% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Kanabo Group-892.40% -80.03% -20.89%
Sourcebio International N/A N/A N/A

In the previous week, Kanabo Group had 2 more articles in the media than Sourcebio International. MarketBeat recorded 2 mentions for Kanabo Group and 0 mentions for Sourcebio International. Kanabo Group's average media sentiment score of 0.00 equaled Sourcebio International'saverage media sentiment score.

Company Overall Sentiment
Kanabo Group Neutral
Sourcebio International Neutral

Summary

Sourcebio International beats Kanabo Group on 6 of the 9 factors compared between the two stocks.

How does Kanabo Group compare to OptiBiotix Health?

OptiBiotix Health (LON:OPTI) and Kanabo Group (LON:KNB) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, valuation, risk, earnings, profitability, institutional ownership and analyst recommendations.

OptiBiotix Health has a beta of 1.71, suggesting that its share price is 71% more volatile than the broader market. Comparatively, Kanabo Group has a beta of 3.04, suggesting that its share price is 204% more volatile than the broader market.

0.4% of OptiBiotix Health shares are owned by institutional investors. Comparatively, 3.8% of Kanabo Group shares are owned by institutional investors. 26.8% of OptiBiotix Health shares are owned by company insiders. Comparatively, 24.3% of Kanabo Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

OptiBiotix Health has higher revenue and earnings than Kanabo Group. OptiBiotix Health is trading at a lower price-to-earnings ratio than Kanabo Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OptiBiotix Health£1.15M5.33-£3.09M-£0.03N/A
Kanabo Group£1.14M1.25-£8.18M-£1.42N/A

OptiBiotix Health has a net margin of -16.59% compared to Kanabo Group's net margin of -892.40%. OptiBiotix Health's return on equity of -2.27% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
OptiBiotix Health-16.59% -2.27% -13.93%
Kanabo Group -892.40%-80.03%-20.89%

In the previous week, Kanabo Group had 1 more articles in the media than OptiBiotix Health. MarketBeat recorded 2 mentions for Kanabo Group and 1 mentions for OptiBiotix Health. OptiBiotix Health's average media sentiment score of 0.37 beat Kanabo Group's score of 0.00 indicating that OptiBiotix Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
OptiBiotix Health
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Kanabo Group
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

OptiBiotix Health beats Kanabo Group on 9 of the 13 factors compared between the two stocks.

Get Kanabo Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for KNB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KNB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KNB vs. The Competition

MetricKanabo GroupMedical Care Facilities IndustryMedical SectorLON Exchange
Market Cap£1.42M£1.70B£6.25B£2.77B
Dividend YieldN/A3.66%2.80%6.15%
P/E Ratio-0.168.7020.64366.02
Price / Sales1.2519.08554.8587,889.69
Price / Cash1.827.9027.4827.89
Price / Book0.241.789.667.63
Net Income-£8.18M£63.03M£3.56B£5.89B
7 Day PerformanceN/A3.22%-1.65%0.61%
1 Month PerformanceN/A6.57%-2.60%0.75%
1 Year PerformanceN/A21.15%30.07%84.26%

Kanabo Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KNB
Kanabo Group
N/AGBX 0.23
flat
N/AN/A£1.42M£1.14MN/A20
TLY
Totally
N/AGBX 0.25
+4.2%
N/A-82.2%£491K£133.05MN/A1,668
SPI
Spire Healthcare Group
2.1799 of 5 stars
GBX 148.20
-4.0%
GBX 291.50
+96.7%
+13.3%£593.69M£1.58B37.05420
MGP
Medica Group
N/AN/AN/AN/A£259.85M£76.98M3,516.671,212
SBI
Sourcebio International
N/AN/AN/AN/A£85.31M£75.61M1,277.78194

Related Companies and Tools


This page (LON:KNB) was last updated on 5/19/2026 by MarketBeat.com Staff.
From Our Partners